A role for CDK4/6 in mitochondrial metabolism is also well supported, whereby increased oxidative mitochondrial metabolism is observed in pancreatic ductal adenocarcinoma cells treated with palbociclib [19], fuelled by increased glutamine consumption and metabolism. This evidence concerns the gene CDK4 and pancreatic ductal adenocarcinoma.